Developed multifunctional TiO2/Pt nanozyme improves antibacterial effects in pressure ulcer treatments, suggesting enhanced healing outcomes.
Pressure ulcer (PU) cause metabolic disorders and ischemia via prolonged pressure, leading to secondary infection, inflammation, and vascular neuropathy. However, existing therapies rely on microenvironment, H2O2, low repair efficiency, and lack efficient collaborative therapy. Herein, a confined multifunctional TiO2/Pt nanozyme is developed via atomic layer deposition for PUs repair. Pt doping narrowed the TiO2 bandgap (3.30→3.05 eV), enhance visible-light-driven •OH generation, and achieves 100% and 97.38% antibacterial efficacy against E. coli and S. aureus by visible photodynamic therapy (PDT). Demonstrating robust CAT/SOD-like activities, it neutralizes ROS in wound microenvironments. For clinical translation, the nanozyme is embedded into a thermosensitive chitosan/β-glycerophosphate hydrogel (TPCG) and combined with a compressible chitosan/nanofibrillated cellulose aerogel. In vitro and in vivo therapeutic experiments, the TPCG hydrogel have proved that in TPCG hydrogel can sterilize and neutralize ROS by visible light while producing O2 to promote cell migration, angiogenesis and reduce inflammation, thereby promoting PU healing, while the aerogel mitigated mechanical stress. Biosafety assays confirmed negligible systemic toxicity. This work provides a synergistic strategy combining nanocatalytic therapy, PDT, and biomechanical support for advanced PU management.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: